Hubei Goto Biopharm Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 302.679 million compared to CNY 202.068 million a year ago. Operating income was CNY 40.829 million compared to CNY 18.587 million a year ago. Net income was CNY 41.043 million compared to CNY 18.682 million a year ago. Basic earnings per share from continuing operations was CNY 0.43 compared to CNY 0.22 a year ago.